Sector: health
Conviction from: NASDAQS&P
52-week range: 591.52991.73
Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, and commercializes medicines, including the eye drug Eylea and the immunology treatment Dupixent.
4 tracked filer(s) hold this · 0 opened, 4 added, 0 trimmed in 30-SEP-2026
Aggregate 13FScore 58 — mean of 4 scored holder(s) · buyers (new/add) avg 58. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Bridgewater | 55 | Added +106% | 105,934 | $80,326,574 | 0.3% |
| Paul Tudor Jones / Tudor | 61 | Added +328% | 54,804 | $41,556,229 | 0.1% |
| Steve Cohen / Point72 | 75 | Added +6224% | 126,480 | $95,905,990 | 0.1% |
| Ancora | 42 | Added +21% | 76 | $57,629 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
3 disclosed trade(s) by 3 filer(s).
11 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-09-22 | Trump, Donald J President | BUY | $50,001 - $100,000 | PTR |
| 2026-09-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-08-22 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-08-22 | Trump, Donald J President | SELL | $100,001 - $250,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $100,001 - $250,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| Report | Date | Stance |
|---|
| #102 — GLP-1s: The Second Serving - Revisiting our GLP-1 Basket | 2025-07-24 | WATCH |